Gut transit time and pH shape microbiome individuality and dietary responses

Scientists reveal gut transit time and pH as key drivers of microbiome and metabolic individuality, paving the way for personalized dietary strategies.

Filament Health Announces signing of definitive agreement for convertible note financing, closing of $900,000 non-brokered private placement financing | Psychedelic Invest

Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) (FSE: 7QS) (“Filament” or the “Company“), a clinical‐stage natural psychedelic drug development company, is pleased to announce that, further to

December 6, 2023

Inside Ibogaine: The Overlooked Yet Promising Psychedelic for Addiction Recovery | Psychedelic Spotlight

Imagine sitting in a movie theater – all alone. The movie you’re watching seems very familiar and in fact, you know all the actors in

June 26, 2023

FDA accept NextPoint Therapeutics IND for HHLA2 targeting mAb – Pharmaceutical Technology

Share this article Nextpoint’s drug candidate is being investigated to treat patients with solid tumours that express tumour antigen HHLA2, such as some breast and

December 8, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.